{"rewrite":{"id":"r_6389430fb60078521e934370","clusterId":"c_564beda6fd824e142195ea02","slug":"global-anorexia-and-bulimia-cases-rise-71-as-experts-flag-glp-1-misuse","model":"deepseek-v4-1-flash","headline":"Global Anorexia And Bulimia Cases Rise 71% As Experts Flag GLP-1 Misuse","summary":"A new analysis published in JAMA Psychiatry on October 28 estimates that anorexia nervosa and bulimia nervosa rose 71% worldwide between 1990 and 2023. Led by Dr. Bai Luhai of the Children's Hospital of Nanjing Medical University, the study covered 204 countries and regions and put the 2023 total at about 18.1 million people. Professor Cheri Levinson of the University of Louisville, who was not involved, says many of her patients are misusing GLP-1 weight-loss drugs.","whyItMatters":"The study counts only anorexia and bulimia, and Levinson says those two make up less than half of all eating disorders, so the 71% figure is a floor rather than the full scale of the problem.","webCardHtml":"\u003cp\u003eThe estimate rests on data pooled from studies and surveys across 204 countries and regions, with statistical models filling gaps. Bai\u0026#39;s team also measured the health burden in disability-adjusted life years: about 3.83 million healthy life years lost worldwide in 2023. The same model projects 21.8 million cases of the two disorders by 2050. Levinson, who has treated eating disorders for about 20 years, places the blame for part of the worsening on GLP-1 drugs, which she says many of her patients misuse. Bai\u0026#39;s paper does not make that connection.\u003c/p\u003e","blueskyPost":"Anorexia and bulimia rose 71% worldwide from 1990 to 2023, per a JAMA Psychiatry analysis out October 28. About 18.1 million people had one of the two in 2023. A University of Louisville psychologist not involved in the study says many of her patients misuse GLP-1 drugs.","twitterPost":"Anorexia and bulimia rose 71% worldwide between 1990 and 2023, a JAMA Psychiatry analysis finds. About 18.1 million people had one of the two in 2023. A psychologist not involved in the study links part of the worsening to GLP-1 misuse.","threadsPost":null,"newsletterBlurb":"A JAMA Psychiatry analysis published October 28 puts the rise in anorexia nervosa and bulimia nervosa at 71% worldwide between 1990 and 2023, with about 18.1 million people affected in 2023. Dr. Bai Luhai's team covered 204 countries and regions. Professor Cheri Levinson, who did not take part in the study, says many of the patients she treats are misusing GLP-1 weight-loss drugs.","attributionJson":"[{\"source\":\"ASCII.jp\",\"url\":\"https://ascii.jp/elem/000/004/448/4448052/?rss\",\"title\":\"Anorexia and Bulimia Up 71% Worldwide, Experts Warn of GLP-1 Drug Misuse\"}]","lintFlagsJson":null,"lintHits":0,"costUsd":0,"inputTokens":5500,"outputTokens":775,"status":"published","repairAttempts":0,"nextRepairAt":null,"factsAttemptedAt":1793743491,"createdAt":"2026-11-03T21:59:17.000Z","publishedAt":"2026-11-03T22:03:51.000Z","updatedAt":"2026-11-03T22:03:51.000Z"},"cluster":{"id":"c_564beda6fd824e142195ea02","canonicalTitle":"拒食症・過食症が世界で71%増、専門家はGLP-1薬の誤用に警鐘","representativeArticleId":"a_961f82653f423518473c97dc","sourceCount":1,"writtenSourceCount":1,"writeAttempts":0,"isSolo":true,"entitiesJson":"{\"anime_titles\":[],\"manga_titles\":[],\"work_titles\":[],\"studios\":[],\"people\":[],\"type\":\"news\",\"domain\":\"other\",\"is_roundup\":false}","contentType":"news","status":"published","firstSeenAt":"2026-11-03T20:57:17.000Z","lastSeenAt":"2026-11-03T20:57:17.000Z","updatedAt":"2026-11-03T22:03:51.000Z"},"attribution":[{"source":"ASCII.jp","url":"https://ascii.jp/elem/000/004/448/4448052/?rss","title":"拒食症・過食症が世界で71%増、専門家はGLP-1薬の誤用に警鐘"}],"entities":{"anime_titles":[],"manga_titles":[],"work_titles":[],"studios":[],"people":[],"type":"news","domain":"other","is_roundup":false},"keyFacts":["The analysis was published in JAMA Psychiatry on October 28.","Anorexia nervosa and bulimia nervosa rose 71% worldwide between 1990 and 2023.","About 18.1 million people had one of the two disorders in 2023.","Dr. Bai Luhai of the Children's Hospital of Nanjing Medical University led the research, which covered 204 countries and regions.","Professor Cheri Levinson of the University of Louisville says many of her patients are misusing GLP-1 weight-loss drugs."],"pageLinks":{"healthSlugs":[],"storySlugs":[],"entities":[],"stories":[],"entitiesOk":true,"storiesOk":true}}